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Abstract
The serum- and glucocorticoid-regulated kinase
(Sgk1) is essential for hormonal regulation of ENaC-
mediated sodium transport and is involved in the
transduction of growth-factor-dependent cell survival
and proliferation. The identification of molecular
partners for Sgk1 is crucial for the understanding of
its mechanisms of action. We performed a yeast two-
hybrid screening based on a human kidney cDNA
library to identify molecular partners of Sgk1. As a
result the screening revealed a specific interaction
between Sgk1 and a 60 kDa Lysophospholipase
(LysoLP). LysoLP is a poorly characterized enzyme
that, based on sequence analysis, might possess
lysophospholipase and asparaginase activities. We
demonstrate that LysoLP has indeed a
lysophospholipase activity and affects metabolic
functions related to cell proliferation and regulation
of membrane channels. Moreover we demonstrate in
the Xenopus oocyte expression system that LysoLP
downregulates basal and Sgk1-dependent ENaC
activity. In conclusion LysoLP may represent a new
player in the regulation of ENaC and Sgk1-dependent
signaling.
Introduction
The serum- and glucocorticoid-induced kinase Sgk1
is a serine/threonine kinase that regulates sodium
absorption by the amiloride-sensitive epithelial sodium
channel (ENaC) in principal cells of the distal nephron
[1, 2]. The kinase is upregulated at the transcriptional
level and/or activated by a wide variety of hormones [3,
4]. It is also considered an important molecular target
that integrates multiple endocrine inputs in the regulation
of several ion channels (ENaC, TRPV5, ROMK,
KCNE1/KCNQ1, ClCKa/Barttin), carriers (NCC,
NKCC, NHE3, SGLT1, EAAT1-5) and the Na+/K+-
ATPase [5-7].
The steroid hormone aldosterone increases the
synthesis of Sgk1, whereas activation of the enzyme is
dependent on phosphorylation. PDK2 (phosphoinositide-
dependent kinase 2) has finally been identified as mTOR
and found to be the H-motif kinase that phosphorylates
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Sgk1 at S422 to prime it for phosphorylation by PDK1 at
T256 [8]. Sgk1 is also involved in mediating growth
factor-, insulin-, IL-2- and steroid-dependent survival
signals [9, 10].
ENaC activity is also down regulated by the activation
of the mitogen-activated protein kinases ERK 1/2 in
response to stimuli as different as lipopolysaccharides [11]
or PKC [12].
Our laboratory has recently demonstrated that Sgk1
phosphorylates and activates MDM2, driving p53 to
proteosomal degradation, thus disclosing a possible
mechanism by which Sgk1 protects cells from stress-
dependent apoptosis [13].
We have also used yeast two-hybrid screening to
identify Sgk1-binding partners. We characterized the
interaction of Sgk1 and phosphomannomutase 2 (PMM2),
showing that PMM2 activity is inhibited by Sgk1 [14].
The identification of other Sgk1-interacting molecular
partners may be important for understanding the
mechanisms inducing channel regulation and transduction
of survival signals.
In the present paper we describe a novel Sgk1-
interacting protein known as 60 kDa Lysophospholipase
(from now on referred to as LysoLP) that, based on
sequence data, is expected to possess lysophospholipase
and asparaginase activities [15]. We present evidence of
physical interaction between LysoLP and Sgk1. Moreover,
we demonstrate that LysoLP increases ERK1/2
phosphorylation and has a measurable effect on the
metabolism of lysophospholipids. Finally, we show, in
Xenopus oocytes, that the expression of LysoLP
decreases membrane expression of ENaC and inhibits
basal and Sgk1-dependent activation of ENaC measured
by two-electrode voltage-clamping.
Taken together, our data suggest that LysoLP can
be considered a new player in Sgk1-dependent regulation
of channel and transporter activities.
Materials and Methods
Constructs
pBridge-2.1 and pBridge-4.1. Sgk1 mutants 2.1 (inac-
tive) and 4.1 (dominant negative) [4, 5] were cloned into pBridge
by means of a PCR-based method, using primers with EcoRI
and BamHI restriction sites according to previously published
methods [14]. pcDNA4/TO/Myc-Sgk1 was used for
transfection in mammalian cells [9].
pCMV-HA-LysoLP. LysoLP, from pACT2-LysoLP was
subcloned into pCMV-HA using the EcoRI-XhoI restriction
sites of the pACT2-LysoLP, selected from the human kidney
library, and used for the yeast two-hybrid assay (BD
Biosciences/Clontech, Palo Alto, CA).
pACT2-LysoLP(Ank). A deletion mutant of LysoLP,
containing the ankyrin repeats, lacking of the first 1265 bp at
the N-terminal portion of LysoLP, was cloned in pACT2. The
coding sequence was amplified by Klen Taq polymerase, using
pACT2-LysoLP as a template. Primers introducing EcoRI (CCG
AAT TCG AGA GGC AGA TGC CCT GCG GAA T) and XhoI
(GTG AAC TTG CGG GG TTT TTC AG) restriction sites were
used.
pGEX-4T-3-LysoLP. The full-length human LysoLP cDNA
was cloned in pGEX-4T-3 (Amersham Biosciences, Freiburg,
Germany). The coding sequence of LysoLP, was amplified by
PCR, using pACT2-LysoLP as template. Primers introducing
EcoRI (CCG AAT TCC ATG GCG CGC GCG GTG GGG) and
XhoI (GAC TCG AGC TTA GAC ACC AGG CAG CAC) restric-
tion sites were used.
pcDNA3-LysoLP. The amplified coding sequence of
LysoLP (see above), was also subcloned into pCDNA3 at
EcoRI-XhoI restriction sites.
pcDNA3 HA-B-Raf and pcDNA3 HA-B-Raf S364A were
kindly provided by Kun-Liang Guan University of Michigan,
Ann Arbor, Michigan, USA.
pEF Myc-B-Raf was kindly provided by Massimo Santoro,
Federico II University, Napoli, Italy.
Yeast Two-Hybrid Screening
A yeast two-hybrid system assay was performed
(MATCHMAKER Gal4 Two-Hybrid; BD Biosciences/Clontech,
Palo Alto, CA). The plasmid pBridge-Sgk1 expressing a fusion
protein with GAL4 DNA binding domain and human full-length
Sgk1 was used as bait. The detailed protocol was described in
a previous study [14]. The cDNA encoding specific Sgk1-
interacting proteins were sequenced and studied with BLAST
analysis. Specificity of the interaction was tested by AH109
co-transformation of the selected plasmid with pBridge-Sgk1
and two unrelated baits (pBridge-Adducin and pBridge empty
vector).
Interaction assay in yeast
Transformed yeast cells were grown in selective medium
for 24 h and then harvested. Cells were lysed, and ONPG
substrate was added. OD was determined by a
spectrophotometer. This ONPG/β-Gal assay is referred to as
the “Miller” assay, and a standardized amount of β-Gal activity
(a “Miller Unit”), is calculated as:
Cells and transfections
COS7 monkey kidney cells and 293T modified human
embryonic kidney fibroblasts (HEK-293T) cells were grown in
DMEM containing 10% fetal bovine serum at 37°C with 5%
CO2. Cells were plated at 70-80% density in six-well plates. On
the next day they were transfected with expression plasmids
(600 ng/well) using Lipofectamine plus reagent (Invitrogen,
Carlsbad, CA) according to the manufacturer’s instructions.
Twenty four hours following transfection, the medium was
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replaced with serum-free medium (DMEM containing 0.1%
insulin-free bovine serum albumin plus antibiotics).
Co-immunoprecipitation Experiments
Co-transfected cells were lysed in a solubilization buffer
containing 50 mM Tris HCl pH 7.8, 300 mM NaCl, 5 mM EDTA,
0.5% Triton X-100, 10 mM NaF, 5 mM sodium pyrophosphate,
2 mM sodium orthovanadate and complete protease inhibitors
(Complete Roche Molecular Biochemicals, Mannheim,
Germany). Protein extracts were quantified by a Bradford-based
assay and immunoprecipitated with the co-immunoprecipitation
kit (Pierce, Rockford, IL) following the manufacturer’s
instructions. Immunoprecipitates were then subjected to
Western blot analysis.
Western blot analysis
Proteins were separated by SDS-PAGE and transferred
onto PVDF membranes. Filters were blocked in 5% non-fat dry
milk, incubated with the appropriate primary antibodies, washed
three times, and incubated with the secondary antibodies.
Protein bands were detected by ECL. Primary antibodies used
were: anti-HA and anti-Myc (diluted 1:1000) from Santa Cruz
Biotechnology (Santa Cruz, CA,USA), and anti-p-ERK1/2
(diluted 1:1000) and anti-ERK (diluted 1:10000) from Cell
Signaling Technology (Beverly, MD).
Preparation of GST-LysoLP
The bacterial strain BL21 was transformed with the pGEX-
4T-3-LysoLP construct. Bacteria were exponentially grown at
37°C for 2 h and subsequently induced with 0.5 mM isopropyl-
1-thio-D-galactopyranoside for 3 h at 30°C. Cells were washed,
resuspended in a lysis buffer containing 1% Triton X-100, 0.1%
glycerol, and 1 mM dithiothreitol, in phosphate-buffered saline
(PBS) supplemented with protease inhibitors (Complete Roche
Molecular Biochemicals, Mannheim, Germany). The GST-
LysoLP fusion protein was subsequently purified by
glutathione Sepharose beads (Pharmacia/Pfizer) and dialyzed
overnight at 4°C against a buffer containing 50 mM Tris HCl
pH 7.5, 1 mM EDTA and 50 mM NaCl. The concentration of
GST-LysoLP was calculated by the Bradford method and verified
by SDS-PAGE and Coomassie blue staining.
Pull-down assay
GST-LysoLP bound to Sepharose beads was mixed with
500 µg of protein extracts of COS7 cells transiently transfected
with pcDNA4/TO/Myc-Sgk1 in a buffer containing 20 mM Tris
HCl 7.4, 0.1 mM EDTA, 100 mM NaCl, 0.5% NP40. The reaction
mixture was incubated for 1 h at room temperature. After
extensive washing with buffer, the beads were incubated for 10
min in Laemmli buffer, and the supernatant was electrophoresed
on a 12% polyacrylamide gel and analyzed by Western blotting.
Immunofluorescence
Forty eight hours following transfection, cells were
washed twice with PBS and fixed for 15 min in 4%
paraformaldehyde in PBS. Fixed cells were washed twice with
PBS and then permeabilized for 5 min with 0.2% Triton X-100 in
PBS. Permeabilized cells were incubated in a humidified chamber
at room temperature with primary antibodies (rabbit polyclonal
anti-Myc, Santa Cruz Biotechnology, Santa Cruz, CA and mouse
monoclonal anti-HA, Roche Diagnostics, Indianapolis, IN)
diluted 1:200 in PBS for 1 h, washed twice with PBS, incubated
for 45 min with an appropriate secondary antibody (Alexa Fluor
488 goat anti-rabbit IgGs and Alexa Fluor 568 donkey anti-
mouse IgGs from Molecular Probes, Eugene, OR), diluted 1:800
in PBS, washed twice with PBS, and mounted with Prolong
antifade reagent (Molecular Probes). Visualization was achieved
using a confocal microscope (Leica Microsystems, Wetzlar,
Germany).
Lysophospholipase activity
HEK293T cells transfected with pCMV-HA or HA-LysoLP
were distrupted by sonication in a lysis buffer containing 20
mM Tris HCl pH 7.5, 0.1 mM EDTA, 2 mM β-mercaptoethanol,
1 mM DTT, 10% glycerol and complete protease inhibitors
(Sigma, St. Louis, MO) as reported before [13]. Cell lysates
were centrifuged at 200 x g for 5 min at 4°C and the postnuclear
supernatants further centrifuged at 10,000 x g for 20 min at 4°C.
The final membrane pellet was resuspended in lysis buffer.
Ninety µg of membranes were incubated with 0.2 mM
LysoGroPIns from bovine liver (Avanti Polar Lipids, Alabaster,
AL) and 15,000 cpm/sample of [3H]-LysoGroPIns in 20 mM
sodium phosphate pH 6, for 2 h at 37°C.
The incubations were terminated by addition of cold
methanol (-20°C), followed by two-phase extraction,
lyophilization of the resultant upper (aqueous) phase and HPLC
analysis [16].
Kinase assay
HEK293T cells transfected with or without LysoLP were
stimulated with insulin (1 µmol) for 30 min. Cell monolayers
were then solubilized, and an aliquot (500 µg) was
immunoprecipitated with rabbit anti-Sgk1 antibody (7 µl).
An artificial substrate peptide (Arg-Pro-Arg-Thr-Ser-Thr-Phe,
1 mM) was used for the immune complex kinase assay (1 mM),
as previously reported [4]. Background incorporation of
radioactivity was estimated by assaying extracts prepared from
untransfected cells incubated in the presence or absence of
insulin. To determine the kinase activity of Sgk1, the average
level of background 32P incorporation was subtracted from 32P
incorporation catalyzed by extracts of transfected cells.
Oocyte preparation; injection of cRNA and
electrophysiological recordings
Electrophysiological recordings were performed using
two-electrode voltage clamp techniques. cRNAs encoding the
rat ENaC α, β and γ subunits (generously provided by B.
Rossier, Lausanne, Switzerland), human Sgk1 [17], and LysoLP
cRNA were synthesized in vitro [18]. Oocytes were injected
with 15 ng human Sgk1, 10 ng LysoLP cRNA or H2O on the first
day after preparation of the oocytes. One day later, 1 ng/subunit
rat wild-type ENaC α, β and γ subunits cRNA were injected. All
experiments were performed at room temperature 4 days after
injections. Two-electrode voltage-clamp recordings were per-
formed at a holding potential of -80 mV [19]. The data were
filtered at 10 Hz and recorded with a GeneClamp 500 amplifier, a
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DigiData 1322A A/D-D/A converter, and the pClamp 9.0 soft-
ware package for data acquisition and analysis (Axon Instru-
ments, USA) [20]. The bath solution (superfusate/ND96) con-
tained 5 mM HEPES pH 7.4, 96 mM NaCl, 2 mM KCl, 1.8 mM
CaCl2 and 1 mM MgCl2. The amiloride-sensitive current was
measured with 50 µM amiloride for 2 min. Epithelial sodium
channel currents were calculated as the difference in whole-
cell current before and after the addition of amiloride to the
bathing solution. The flow rate of the superfusion was 20 ml/
min, and a complete exchange of the bath solution was reached
within about 10 s. Data are provided as means ± SEM, for n
oocytes investigated. All experiments were repeated with at
least three batches of oocytes; in all repetitions qualitatively
similar data were obtained.
Western Blot of Plasma Membrane Proteins
The membrane abundance of Flag-βENaC was analyzed
by surface biotinylation. Twenty intact healthy oocytes were
incubated in Sulfo-NHS-LC-Biotin (1 mg/ml, Pierce, Rockford,
IL, USA) for 30 minutes at room temperature and washed 5
times for 10 min in ND96. The oocytes were homogenized with
a pestle in 400 µl buffer H (20 mM Tris HCl, pH 7.4, 100 mM
NaCl,  1% TritonX-100 and Complete Protease Inhibitor [(Roche
Diagnostics GmbH, Mannheim, Germany]). The samples were
kept at 4°C for 1 h on a rotator, and then centrifuged for 1 min at
13,000 rpm. The supernatants were supplemented with 25 µl
washed immobilized NeutrAvidin Agarose beads (Pierce,
Rockford, IL, USA) and incubated at 4°C overnight on a rota-
tor. The beads were then pelleted by a 2 min centrifugation at
13,000 rpm, and washed in buffer H (5 times). Proteins were
separated on a 10% polyacrylamide gel and transferred to PVDF
membrane. After blocking with 5% non-fat dry milk in TBS
0.1% Tween20 for 1 h at room temperature, the blots were incu-
bated overnight at 4°C with mouse anti-Flag M2 antibody (di-
luted 1:1,000, Sigma Aldrich, Saint Louis, Missouri, USA). Af-
ter washing (TBST), the blots were incubated with anti-mouse
HRP-conjugated antibody (diluted 1:1,000, Cell Signaling,
Danvers, MA, USA) for 1 h at room temperature. Antibody
binding was detected with the ECL detection reagent
(Amersham, Freiburg, Germany). Bands were quantifed with
Quantity One Software (Bio-Rad, München, Germany).
Results
Identification of the 60 kDa lysophospholipase
as an Sgk1 molecular partner
The two-hybrid screening resulted in the isolation of
a yeast clone containing an ~1700 bp cDNA. Other clones
selected by the screening were previously reported [12].
BLAST analysis of the 1700-bp-cDNA showed that the
isolated contains the full-length sequence coding for a
protein named 60 kDa Lysophospholipase (LysoLP)
(NP_001073933). Specificity of the interaction was
demonstrated by re-transforming the selected clone with
the bait (pBridge-Sgk1) and two other unrelated baits
(pBridge-Adducine and pBridge empty vector). Only co-
transformation of pACT2-LysoLP with pBridge-Sgk1
allowed the growth of the yeast in selective media.
The gene encoding LysoLP maps at the position
14q32.33. LysoLP is a protein with a predicted asparagi-
nase domain in the amino-terminal region and four ankyrin
domains in the carboxy-terminal region (Fig. 1).
The strength of the interaction between Sgk1 and
LysoLP was measured by means of a β-galactosidase
assay. Sgk1 kinase activity was not necessary for the
interaction with LysoLP, since both kinase dead (S422A)
(clone 2.1) and dominant negative (D222A) (clone 4.1)
Sgk1 mutants were as effective as the wild-type in the
interaction with LysoLP (Table 1). An amino terminal
deletion mutant of LysoLP, LysoLP(Ank) containing the
four ankyrin domains, was generated. When tested for
the interaction with Sgk1, turned out to be significantly
less efficient than the full-length LysoLP (Table 1).
Sgk1/LysoLP interaction in mammalian cells
Myc-tagged Sgk1 and HA-LysoLP-expressing vec-
tors were co-transfected in COS7 cells. Proteins were
extracted and subjected to immunoprecipitation as de-
Fig 1. Predictive structure of 60
kDa lysophospholipase. The
amino-terminal asparaginase
domain and the carboxy-terminal
ankyrin domains are boxed.
Table 1. Interaction assay in yeast
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scribed in the section of materials and methods. Co-
immunoprecipitation of LysoLP with anti-Myc Sepharose
beads was observed only in the presence of Sgk1. Co-
immunoprecipitation of Sgk1 with anti-HA Sepharose
beads was observed only in the presence of LysoLP (Fig.
2 A).
The interaction of LysoLP and Sgk1 was confirmed
by a pull-down assay. Pull-down experiments were car-
ried out by applying protein extracts from COS7 cells
transiently transfected with pcDNA4/TO/Myc-Sgk1 to
columns containing either recombinant purified GST or
GST-fused LysoLP. Myc-Sgk1 was detected by West-
ern blotting with anti-Myc immunoglobulins only in the
eluates obtained from the GST-LysoLP columns (Fig. 2
B).
Finally, extensive co-localization of Sgk1 and LysoLP
in the cytoplasm of co-transfected COS7 cells was ob-
served (Fig. 2. C).
Lysophospholipase assay
An in vitro lysophospholipase assay was carried out
using [3H]-lysoglycerophosphocholine (LysoGroPCho)
and [3H]-lysoglycerophosphoinositol (LysoGroPIns) as
Fig 2. Sgk1 and LysoLP interaction. A:
Sgk1 and LysoLP co-immunopre-
cipitation. COS7 cells were transfected
with empty vector (lane K), pcDNA4/
TO/Myc-Sgk1 (lane A), pCMV-HA-
LysoLP (lane B) and both pcDNA4/TO/
Myc-Sgk1 and pCMV-HA-LysoLP
(lane C). Protein extracts (left panels)
and anti-Myc or anti-HA immunopre-
cipitates (IP, left panels) were analyzed
by SDS-PAGE and revealed by
immunoblotting with anti-HA (upper
panels) and anti-Myc immunoglobulins
(lower panels) as indicated. B: Sgk1 and
GST-LysoLP pull-down assay. Cell
lysates from COS7 cells transfected
with pcDNA4/TO/Myc-Sgk1 were
allowed to bind a resin containing
recombinant GST or GST-fused LysoLP.
Myc-tagged Sgk1 was detected in SDS
eluates by immunoblotting with anti-
Myc antibodies. C: Co-localization of
Sgk1 and LysoLP. Monolayers of COS7
cells grown on glass coverslips were transfected with expression vectors encoding the full-length Myc-tagged Sgk1 (pcDNA4/
TO/Myc-Sgk1) and the full-length HA-tagged LysoLP (pCMV-HA-LysoLP). Serum-starved cells were fixed as indicated in
materials and methods and stained with rabbit anti-Myc immunoglobulins to visualize Sgk1 or with mouse anti-HA immunoglobulins
to visualize LysoLP. The staining for Sgk1 was detected with Alexa Fluor 488 goat anti-rabbit IgGs. The staining for LysoLP was
detected with Alexa Fluor 568 donkey anti-mouse IgGs.
Fig 3. Lysophospholipase activity. A: HEK 293T cells were
transfected with either empty vector (lane K) or pCMV-HA-
LysoLP (lane A). Proteins extracts were analyzed by SDS-PAGE
and revealed by immunoblotting with anti-HA. B:
Lysophospholipase activity was measured as radioactivity
associated with GroPIns recovered after 2-h-incubation of 90
ug membrane proteins from either pCMV-HA (open bar) or HA-
LysoLP-transfected cells (closed bar) with 0.2 mM LysoGroPIns
and 15,000 cpm/sample of [3H]-LysoGroPIns in 20 mM sodium
phosphate pH 6 (see also materials and methods). Data are
expressed as percentage of empty-vector-transfected
membranes and are mean ± SEM of 5 experiments in duplicates.
* (p<0.05).
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substrates, in the presence of cell membranes purified
from HEK293T cells transfected and not with vectors
coding for HA-LysoLP. The overexpression of LysoLP
was associated with a modest (~20%) but still significant
increase in the lysophospholipase activity detected in cell
membranes toward LysoGroPIns (Fig. 3), while no activity
was monitored in presence of LysoGroPCho. This
lysophospholipase activity was not affected by the co-
expression of Sgk1 in HEK293T cells, suggesting that
the interaction between LysoLP and Sgk1 has no effect
on the lysophospholipase activity associated with LysoLP.
The effects of Sgk1 and LysoLP expression on
ERK1/2 phosphorylation
In HEK293T the transient transfection with the
vector coding for wild-type Sgk1 was associated with a
sharp decline in the phosphorylation of ERK1/2 (Fig. 4
B, lane A) . On the contrary, in HEK293T cells transiently
transfected with LysoLP a clear-cut increase in the
phosphorylation of ERK1/2 was detected, (Fig. 4 B, lane
B). The co-transfection of both LysoLP and Sgk1 resulted
in a level of ERK1/2 phosphorylation that ranked in
between the stimulatory effect of LysoLP and the
inhibitory effect of Sgk1 (Fig. 4 B , lane C).
Sgk1 has previously been shown to negatively
regulate the Raf pathway [21]. Transfection of wild type
B-Raf [22], strongly enhanced ERK1/2 phosphorylation
(Fig. 4 C, lane K’). The effect of Sgk1 and LysoLP on
ERK1/2 phosphorylation was also maintained in
HEK293T cells over-expressing wild type B-Raf thus
suggesting that Sgk1 acts on both endogenous and
exogenous B-Raf (Fig. 4 C, lanes A’, B’ and C’). In order
to better characterize the Sgk1 dependent regulation of
B-Raf further experiments were carried out in HEK293T
cells over-expressing either wild type or mutant B-Raf
[21]. Sgk1co-transfection significantly decreased B-Raf
dependent ERK1/2 phosphorylation, in presence of wild
type B-Raf. (Fig. 4 D, lane A’) . Interestingly when
HEK293T cells were transfected with a Ser364Ala B-
Raf mutant lacking Ser364, that is the target of Sgk1
dependent inhibitory phosphorylation of B-Raf [21], a
significant increase in ERK1/2 phosphorylation was
Fig 4. ERK1/2 phosphorylation. A: HEK
293T cells were transfected with empty
vectors (lane K) or vectors coding for
wild-type Myc-Sgk1 (laneA), HA-
LysoLP (laneB), or both wild-type Myc-
Sgk1 and HA-LysoLP (lane C). Cell
extracts were separated by SDS-PAGE
and transferred to nitrocellulose. Blots
were incubated with anti-HA and/or anti-
Myc immunoglobulins as indicated. B:
Blots prepared from cell extracts as
described in panel A were incubated with
phospho-ERK immunoglobulins (panel
B, top ) and ERK immunoglobulins for
normalization (panel B, bottom). The
results are representative of three
independent experiments. C: HEK 293T
cells were transfected with empty vectors
(lane K) or vectors coding for wild-type
Myc B-Raf (lane K’), wild -type Myc B-
Raf and Myc-Sgk1 (laneA’), wild -type
Myc B-Raf and HA-LysoLP (laneB’ ), or
wild-type Myc B-Raf, wild-type Myc-
Sgk1 and Ha-LysoLP (lane C’). Cell
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detected (Fig. 4 D, lane K’’), although this phosphorylation
was not inhibited by Sgk1 co-transfection, thus
demonstrating that Ser364 on B-Raf is indeed necessary
for Sgk1 dependent B-Raf inhibition (Fig. 4 D, lane A’’).
Sgk1 kinase activity
The heterologous expression of LysoLP was unable
to affect the kinase activity. HEK293T cells, transfected
with or without a vector coding for LysoLP, were treated
with insulin, a well known activator of Sgk1 [4].
Endogenous Sgk1 was immunoprecipitated and used in
an in vitro kinase assay with an artificial substrate and in
the presence of [γ32P]-ATP. Insulin consistently enhanced
Sgk1 kinase activity whereas the overexpression of the
LysoLP had no effect on either the basal or insulin-
stimulated Sgk1-dependent kinase activity (Fig. 5).
The effect of LysoLP on ENaC activity
The effect of LysoLP on the regulation of the
amiloride-sensitive epithelial sodium channel ENaC was
studied in isolated Xenopus oocytes expressing ENaC in
the absence or presence of LysoLP and Sgk1. (Fig. 6 A
and B ). ENaC-dependent current was increased by the
expression of Sgk1, an effect totally reversed by
coexpression of LysoLP (Fig. 6 A ).
Fig 5. Sgk1 kinase activity, effects of insulin and LysoLP. HEK
293T cells transfected, with either pCMV-HA empty vector or
vector coding for HA-LysoLP, were stimulated for 30 min with
insulin (1 µmol). Endogenous Sgk1 was immunoprecipitated
by Sgk1-specific immunoglobulins. The kinase activity associ-
ated with Sgk1 immunopreciptates was expressed as radioac-
tivity (cpm) incorporated in an artificial substrate peptide as
indicated in the materials and methods section.
Fig 6. Experiments in Xenopus oocytes. A. Original tracings
of the amiloride-sensitive ENaC-dependent current in Xenopus
oocytes injected with water (a), expressing ENaC without (b, c)
or with additional co-expression of Sgk1 (d, e), in absence (b,
d) or presence of LysoLP (c, e). B. Arithmetic means ± SEM
(n=10-17) of the amiloride-sensitive ENaC-dependent current
in Xenopus oocytes injected with water, expressing ENaC
without or with additional coexpression of Sgk1 in the absence
(open bars) or presence (closed bars) of LysoLP. *** (p<0.001)
indicates statistically significant difference from the absence
of Sgk1. ### (p<0.001) indicates statistically significant
difference from the absence of LysoLP. C. Membrane abundance
of Flag-βENaC as detected by surface biotinylation (top). Bands
were quantifed with Quantity One Software (bottom).
The LysoLP dependent inhibition of ENaC-
dependent current was associated with a clear cut
decrease in the membrane expression of ENaC, as
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detected by surface biotinylation, thus demonstrating that
the expression of LysoLP interferes with the membrane
expression of ENaC (Fig. 6 C)
Discussion
Previous data obtained from A6 cells, a well-
characterized model of the principal cells of the distal
nephron, suggested that phosphatidylinositide-3-kinase
(PI3K)-dependent phosphorylation of Sgk1 is essential
for the activation of the enzyme and that it is indeed the
active enzyme, which contributes to or even accounts
for insulin-, vasopressin- and aldosterone-dependent
stimulation of sodium transport through the amiloride-
sensitive ENaC [23]. We performed yeast two-hybrid
screening to identify molecular partners involved in the
transduction of signals through Sgk1. We used a kidney
library as a source of prey cDNAs because the hormonal
regulation of sodium transport takes place in the principal
cells of the distal nephron.
Using two-hybrid screening, we identified several
independent clones coding for putative Sgk1-interacting
proteins [12]. One of them, transportin (related to importin)
has previously been shown by others to interact with the
nuclear localization sequence of Sgk1 and to cause
nuclear import of Sgk1 [24]. Another clone coding for
PMM2, a key enzyme in protein glycosylation, has
previously been characterized [12].
The 60 kDa Lysophospholipase (LysoLP) is a human
clone similar to the rat liver lysophospholipase [15, 25].
Based on sequence analysis the enzyme has been
proposed to be endowed with asparaginase activity,
lysophospholipase activity and hydrolase activity, although
the precise function is so far unknown. Recently, the
official symbol ASPG has been attributed to the protein,
standing for asparaginase homolog (S. cerevisiae) [Homo
sapiens] GeneID: 374569.
Based on the yeast two-hybrid screening, co-
immunoprecipitation and co-localization experiments, we
present evidence for a physical interaction between Sgk1
and LysoLP. The use of an amino terminal mutant of
LysoLP suggested that the N terminal portion of the
molecule is critical for the interaction.
In order to elucidate the function of the new Sgk1-
interacting protein, we started setting up asparaginase
and lysophospholipase assays. We were unable to
associate a consistent asparaginase activity with LysoLP
(data not shown), whereas a mild, but significant,
lysophospholipase activity was detected when
lysophosphatidylinositol was used as substrate. This
activity was not affected by Sgk1, indicating that although
LysoLP and Sgk1 are physically associated, their
interaction does not reciprocally affect their enzymatic
activities.
It is worth remembering that Sgk1 has been
demonstrated to negatively regulate B-Raf by inhibitory
phosphorylation of Serine 364 [19] and is then expected
to inhibit ERK phosphorylation as previously shown in a
kidney cancer cell model [9]. This effect of Sgk1 is
synergic with the effect of GILZ that enhances the
activity of ENaC downregulating the tonic inhibition
exerted by ERK phosphorylation [26], although the
possible cross talk between Sgk1 and GILZ needs to be
better defined. Indeed, a Sgk1-dependent inhibition of
ERK1/2 phosphorylation was confirmed in our system.
The use of the Ser364Ala B-Raf mutant demonstrates
that Sgk1 dependent phosphorylation of Ser364 in B-Raf
is required for the inhibition of Erk1/2 phosphorylation .
Both the inhibition of ERK1/2 phosphorylation and the
Sgk1-dependent stimulation of ENaC activity in Xenopus
oocytes were reverted by co-transfection of LysoLP.
Since we were unable to demonstrate an inhibitory effect
of LysoLP on the kinase activity associated with Sgk1
we consider the possibility of a trapping interaction
between LysoLP and Sgk1 that may result in sequestering
Sgk1 away from its protein substrates. In fact the
expression of LysoLP in frog oocytes appears to decrease
significantly the membrane expression of ENaC, a feature
that is tightly regulated by Sgk1 through phosphorylation
of Nedd4-2 [27].
Taken together, these results are entirely consistent
with previous studies showing that ENaC activity is
decreased in response to increases in ERK activity [26,
28] and suggest a role for ERKs in the observed effects.
The lysophospholipase activity associated with
LysoLP is indeed expected to have consequences on the
lipid composition of cell membranes. The expression of
LysoLP in HEK293T cells is expected to accelerate the
conversion of lysophosphatidylinositol into
glycerophosphoinositol, which is an intracellular
messenger, derived from the Ras pathway and involved
in the control of cell proliferation [29-31].
Modulation of the lysolipid content may have
structural consequences at the level of the plasma
membrane (decrease in membrane curvature), or, in the
case of LysoPtdIns, can be part of the PI catabolism. On
the other hand GroPIns is a molecule that is involved in
several signal transduction pathways and has been
considered an intracellular messenger in thyroid cells [32],
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thus its Lyso-dependent formation may be part of a
regulatory cascade yet to be uncovered.
The phosphoinositide metabolism plays a crucial role
in transport [33] and has recently been demonstrated to
participate in Sgk1 sensitive transport regulation [34]; both
chelation of endogenous PtdIns45P2 with anti-PtdIns45P2
antibody and hydrolysis of endogenous via exogenous
phospholipase C reduce ENaC activity [35]. In addition,
PI3-kinase and the formation of  PtdIns345P3 are  required
for basal, insulin- and aldosterone-stimulated sodium
transport mediated via ENaC [36, 37].
More recently, the lipid composition of cell
membranes has been demonstrated to be critically
important for the Sgk1-dependent regulation of sodium
transport through ENaC [36, 38]. Thus, changes in
membrane lipid composition mediated by the LysoLP may
also alter channel and transporter activities and may be
responsible for the LysoLP-dependent inhibition of basal
and Sgk1-stimulated sodium transport through ENaC.
In conclusion, we describe a novel molecular partner
of Sgk1 that is similar to a previously identified rat liver
lysophospholipase. Although the functional consequences
of the interaction between Sgk1 and LysoLP remain
unknown, these enzymes have independent and opposing
effects on intracellular processes such as ERK1/2
phosphorylation and ENaC activity. Furthermore, these
studies provide novel information on the function of a
poorly characterized enzyme that is likely to be involved
in the regulation of several Sgk1-dependent functions,
related to cell proliferation and to the regulation of cell
membrane channels.
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